Approaches and Considerations for the Investigation and Synthesis of N -Nitrosamine Drug Substance-Related Impurities (NDSRIs)
Organic Process Research & Development · 20.10.2023 · 27 (10) · 1784-1791
DOI: 10.1021/acs.oprd.3c00084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Process Research & Development, online erschienen am 30.05.2023. Verfasst von Ian W. Ashworth und 7 weiteren Autor:innen. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: AstraZeneca, Pfizer, GlaxoSmithKline.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- AstraZeneca
- Pfizer
- GlaxoSmithKline
- Eli Lilly and Company
- Merck
Zitieren
APA
Ashworth, I. W., Blanazs, A., Byrne, J. J., Dirat, O., Fennell, J. W., Kuhl, N., Wells, S. L., & Whiting, M. P. (2023). Approaches and Considerations for the Investigation and Synthesis of N -Nitrosamine Drug Substance-Related Impurities (NDSRIs). Organic Process Research & Development, 27(10), 1784-1791. https://doi.org/10.1021/acs.oprd.3c00084
Vancouver
Ashworth IW, Blanazs A, Byrne JJ, Dirat O, Fennell JW, Kuhl N, et al. Approaches and Considerations for the Investigation and Synthesis of N -Nitrosamine Drug Substance-Related Impurities (NDSRIs). Organic Process Research & Development. 2023;27(10):1784-1791. doi:10.1021/acs.oprd.3c00084
BibTeX
@article{Ashworth2023,
author = {Ashworth, Ian W. and Blanazs, Alexander and Byrne, Jonathan J. and Dirat, Olivier and Fennell, Jared W. and Kuhl, Nadine and Wells, Stuart L. and Whiting, Matthew P.},
title = {Approaches and Considerations for the Investigation and Synthesis of N -Nitrosamine Drug Substance-Related Impurities (NDSRIs)},
journal = {Organic Process Research & Development},
year = {2023},
volume = {27},
number = {10},
pages = {1784--1791},
doi = {10.1021/acs.oprd.3c00084}
}
EUVIMED